Cargando…
CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism
CD44 is a single-pass cell surface glycoprotein that is distinguished as the first molecule used to identify cancer stem cells in solid tumors based on its expression. In this regard, the CD44(high) cell population demonstrates not only the ability to regenerate a heterogeneous tumor, but also the a...
Autores principales: | Gao, Ruifang, Li, Dan, Xun, Jing, Zhou, Wei, Li, Jun, Wang, Juan, Liu, Chen, Li, Xiru, Shen, Wenzhi, Qiao, Huan, Stupack, Dwayne G., Luo, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299690/ https://www.ncbi.nlm.nih.gov/pubmed/30613295 http://dx.doi.org/10.7150/thno.28721 |
Ejemplares similares
-
PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer
por: Li, Dan, et al.
Publicado: (2022) -
CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4
por: Li, Wei, et al.
Publicado: (2017) -
The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020) -
Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer
por: Sninsky, Jared A., et al.
Publicado: (2021) -
Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
por: Song, Xianghe, et al.
Publicado: (2016)